N. Tran

Prevention of graft-versus-host disease by peptides binding to class II major histocompatibility complex molecules.

M. Vaysburd, N. Chao, R. Aharoni, 1994, Blood.

An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy

W. Liu, Z. Dezső, L. Bigelow, 2022, Nature Cancer.

Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease.

J. Zehnder, N. Chao, D. Thompson, 1997, Blood.

Murinization and H Chain Isotype Matching of the Anti-GITR Antibody DTA-1 Reduces Immunogenicity-Mediated Anaphylaxis in C57BL/6 Mice

D. Hollenbaugh, F. Harding, J. Samayoa, 2017, The Journal of Immunology.

Effect of Elotuzumab on Circulating Lymphocytes, Chemokines, and Cytokines In Multiple Myeloma Patients

J. Sheridan, Yuni Fang, A. Rice, 2010 .